Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (±)-Naringenin

(±)-Naringenin

(±)-Naringenin structure

(±)-Naringenin 

structure
  • CAS No:

    67604-48-2

  • Formula:

    C15H12O5

  • Chemical Name:

    (±)-Naringenin

  • Synonyms:

    4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-;2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;4′,5,7-Trihydroxyflavanone;5,7,4′-Trihydroxyflavanone;(R,S)-Naringenin;(±)-Naringenin;(RS)-Naringenin;(±)-5,7,4′-Trihydroxyflavanone;ST 057236;5,7-Dihydroxy-2-(4-hydroxyphenyl)-4H-chroman-4-one;5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one;TCI-CA 03;93602-28-9

  • Categories:

    Biochemical Engineering  >  Plant Extracts

Description

(±)-Naringenin is a naturally-occurring flavonoid. (±)-Naringenin displays vasorelaxant effect on endothelium-denuded vessels via the activation of BKCa channels in myocytes[1].


Naringenin is a trihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5, 6 and 4'. It is a trihydroxyflavanone and a member of 4'-hydroxyflavanones.

(±)-Naringenin Basic Attributes

272.25

272.25

266-769-1

34875|11855

DTXSID1022392|DTXSID50274239

29329990

Characteristics

87

2.4

1.485g/cm3

248 °C

577.5°C at 760 mmHg

soluble in ethanol (50 mg/ml), DMSO, methanol, and ammonium hydroxide (50 mg/ml). Insoluble in water (almost)

0-6°C

167.96 Ų [M+H]+ [CCS Type: DT, Method: stepped-field]|167.33 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|160.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

3077

3

36/37/38

26-36

DJ2981530

Xi

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 200 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)|Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)

Narigenin has known human metabolites that include Narigenin 7-O-glucuronide.

4',5,7-trihydroxyflavanone

(±)-Naringenin Use and Manufacturing

The aglucon of Naringin. Inhibitory mechanism of Naringenin against carcinogenic acrylamide formation and nonenzymic browning in Maillard model reactions

Computed Properties

Molecular Weight:272.25
XLogP3:2.4
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:272.06847348
Monoisotopic Mass:272.06847348
Topological Polar Surface Area:87
Heavy Atom Count:20
Complexity:363
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of (±)-Naringenin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.